Similar articles

• Drug-induced removal of nitrogen derivatives in urine: a new concept whose time has come.

  Córdoba J, Ventura-Cots M. Córdoba J, et al. Hepatology. 2014 Mar;59(3):764-6. doi: 10.1002/hep.26789. Epub 2014 Jan 27. Hepatology. 2014. PMID: 24123173 No abstract available.
• Randomized, double-blind, controlled study of glycerol phenylbutyrate in hepatic encephalopathy.

  Rockey DC, Vierling JM, Mantry P, Ghabril M, Brown RS Jr, Alexeeva O, Zupanets IA, Grinevich V, Baranovsky A, Dudar L, Fadieienko G, Kharchenko N, Klaryts'ka I, Morozov V, Grewal P, McCashland T, Reddy KG, Reddy KR, Syplyviy V, Bass NM, Dickinson K, Norris C, Coakley D, Mokhtarani M, Scharschmidt BF; HALT-HE Study Group. Rockey DC, et al. Hepatology. 2014 Mar;59(3):1073-83. doi: 10.1002/hep.26611. Hepatology. 2014. PMID: 23847109 Free PMC article. Clinical Trial.
• Treatment of hyperammonemia in liver failure.

  Jover-Cobos M, Khetan V, Jalan R. Jover-Cobos M, et al. Curr Opin Clin Nutr Metab Care. 2014 Jan;17(1):105-10. doi: 10.1097/MCO.0000000000000012. Curr Opin Clin Nutr Metab Care. 2014. PMID: 24281376 Review.
• Efficacy of oral L-ornithine L-aspartate in cirrhotic patients with hyperammonemic hepatic encephalopathy.

  Blanco Vela CI, Poo Ramírez JL. Blanco Vela CI, et al. Ann Hepatol. 2011 Jun;10 Suppl 2:S55-9. Ann Hepatol. 2011. PMID: 22228883
• Pharmacotherapy for hyperammonemia.

  Hadjihambi A, Khetan V, Jalan R. Hadjihambi A, et al. Expert Opin Pharmacother. 2014 Aug;15(12):1685-95. doi: 10.1517/14656566.2014.931372. Expert Opin Pharmacother. 2014. PMID: 25032885 Review.